Webinar – PDX Platform for Clinical Advancement of Oncology Agents

Find out how the Champions TumorGraft platform is being used for conducting high-throughput translational medicine trials across a multitude of patient tumor models, including acute myelogenous leukemia (AML).  Additionally, hear how co-clinical and matched PDX-directed trials are being implemented through several industry and academic partnerships.

Agenda includes:

  • Introduction to the PDX algorithm
  • Overview of Champions Oncology PDX tumor bank
  • Overview of Champions Oncology co-clinical program
  • AML modeling
  • CD34+ HSC-derived humanized PDX models for immuno-therapy testing

Webinar PDX Platform for Clinical Advancement of Oncology Agents

Complete the form below to access the Webinar








Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology